Pages that link to "Q84066365"
Jump to navigation
Jump to search
The following pages link to Minor serous and clear cell components adversely affect prognosis in ''mixed-type'' endometrial carcinomas: a clinicopathologic study of 36 stage-I cases (Q84066365):
Displaying 13 items.
- Practical issues in the diagnosis of serous carcinoma of the endometrium (Q28072095) (← links)
- Molecular Analysis of Mixed Endometrioid and Serous Adenocarcinoma of the Endometrium (Q35679924) (← links)
- Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing (Q35926060) (← links)
- Interobserver Variability in the Diagnosis of Uterine High-Grade Endometrioid Carcinoma (Q36006694) (← links)
- Molecular Analysis of Mixed Endometrial Carcinomas Shows Clonality in Most Cases. (Q37268075) (← links)
- Pathology of Endometrial Carcinoma (Q38788207) (← links)
- Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study (Q39123683) (← links)
- Factors prognostic of survival in advanced-stage uterine serous carcinoma (Q39278980) (← links)
- Does the Loss of ARID1A (BAF-250a) Expression in Endometrial Clear Cell Carcinomas Have Any Clinicopathologic Significance? A Pilot Assessment (Q41875235) (← links)
- Mutation profile and clinical outcome of mixed endometrioid-serous endometrial carcinomas are different from that of pure endometrioid or serous carcinomas (Q43720808) (← links)
- Endometrial stromal sarcoma in combination with mixed type endometrial carcinomas: A case report and literature review (Q47140893) (← links)
- [New features in the 2014 WHO classification of uterine neoplasms]. (Q52981685) (← links)
- Potential of an age-stratified CA125 cut-off value to improve the prognostic classification of patients with endometrial cancer (Q61705507) (← links)